Discontinued Operations

12 Months Ended

Dec. 31, 2014

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

Discontinued Operations

On August 31, 2012, the Company sold all of the shares of common stock of Agera held by the Company, which represented 57% of the outstanding common stock of Agera, to Rohto Pharmaceutical Co., Ltd. for approximately $1.0 million. Accordingly, all operating results from continuing operations exclude the results for Agera which are presented as discontinued operations. The Company recorded a gain for the year ended December 31, 2012 of approximately $0.5 million on the sale.

The financial results of Agera are classified as discontinued operations in the accompanying Consolidated Statement of

Operations for the year ended December 31, 2012.

Summary financial information related to discontinued operations is as follows:

($ in thousands)	Year ended, December 31, 2012
Product sales	$	516
Cost of sales	275
Gross profit	241
Operating income (loss)	$	27
Net loss	$	(2	)

In addition, there were other minimal losses from foreign subsidiaries which were classified as discontinued operations

for the year ended December 31, 2012.